1. Home
  2. RMR vs MASS Comparison

RMR vs MASS Comparison

Compare RMR & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RMR Group Inc.

RMR

The RMR Group Inc.

HOLD

Current Price

$20.43

Market Cap

350.4M

ML Signal

HOLD

Logo 908 Devices Inc.

MASS

908 Devices Inc.

HOLD

Current Price

$8.70

Market Cap

326.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMR
MASS
Founded
1986
2012
Country
United States
United States
Employees
900
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
350.4M
326.0M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
RMR
MASS
Price
$20.43
$8.70
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$19.00
$12.00
AVG Volume (30 Days)
135.8K
295.0K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
10.37%
N/A
EPS Growth
N/A
125.47
EPS
0.77
N/A
Revenue
$700,284,000.00
$56,197,000.00
Revenue This Year
$259.61
$19.44
Revenue Next Year
$2.45
$18.63
P/E Ratio
$26.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.27
$5.03
52 Week High
$21.45
$9.34

Technical Indicators

Market Signals
Indicator
RMR
MASS
Relative Strength Index (RSI) 53.71 55.30
Support Level $20.29 $7.57
Resistance Level $20.52 $9.21
Average True Range (ATR) 0.45 0.44
MACD -0.10 -0.03
Stochastic Oscillator 18.10 47.00

Price Performance

Historical Comparison
RMR
MASS

About RMR The RMR Group Inc.

The RMR Group Inc is a U.S. based real estate investment manager engaged in commercial real estate, private capital, and credit strategies. Its portfolio covers various commercial real estate asset classes, and it manages investments across various industries, geographies and asset classes.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: